» Articles » PMID: 23573088

Elevated Serum Gamma-glutamyltransferase is a Strong Marker of Insulin Resistance in Obese Children

Overview
Publisher Wiley
Specialty Endocrinology
Date 2013 Apr 11
PMID 23573088
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated levels of serum gamma-glutamyltransferase (GGT) levels have been found to predict the development of type 2 diabetes in adults. The role of GGT in insulin resistance (IR) among children is largely unknown. We investigated whether GGT among hepatic enzymes is independently associated with IR in obese Korean children. A total of 1308 overweight (above the 85th BMI percentile of Korean reference) boys (n = 822) and girls (n = 486), aged 9-15 years, were studied. Measures acquired included weight, height, percent body fat (BF%), waist circumference, blood pressure, blood glucose and insulin, C-reactive protein, total cholesterol, triglycerides, HDL-Cholesterol, GGT, aspartate aminotransferase (AST), and alanine aminotransferase (ALT). IR was calculated using the homeostasis model assessment (HOMA-IR). Serum GGT and ALT, but not AST, were positively correlated with HOMA-IR in boys (r = 0.222 for GGT; P < 0.05, r = 0.188 for ALT; P < 0.05) and girls (r = 0.292 for GGT; P < 0.05, r = 0.258 for ALT; P < 0.05). In multiple regression analysis for HOMA-IR as dependent variable, GGT (β = 0.068; P = 0.053 in boys, β = 0.145; P = 0.002 in girls) and ALT (β = 0.074; P = 0.034 in boys, β = 0.130; P = 0.005 in girls) emerged as determinants of HOMA-IR after adjusting age, BMI, tanner stage, and triglycerides. Serum GGT level is a strong marker of IR in obese Korean children.

Citing Articles

Effects of H3 and H4 histones acetylation and bindings of CREB binding protein and p300 at the promoter on hepatic expression of gamma-glutamyltransferase gene in a streptozotocin-induced moderate hypoinsulinemic rat model.

Tanaka T, Mizuno T, Nakagawa T, Hayakawa T, Shimada M Physiol Res. 2021; 70(3):475-480.

PMID: 33982587 PMC: 8820556. DOI: 10.33549/physiolres.934620.


ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.

Sekkarie A, Welsh J, Northstone K, Cioffi C, Stein A, Figueroa J Children (Basel). 2020; 7(9).

PMID: 32882815 PMC: 7552746. DOI: 10.3390/children7090117.


TG : HDL-C Ratio Is a Good Marker to Identify Children Affected by Obesity with Increased Cardiometabolic Risk and Insulin Resistance.

Nur Zati Iwani A, Jalaludin M, Zin R, Fuziah M, Hong J, Abqariyah Y Int J Endocrinol. 2019; 2019:8586167.

PMID: 31885562 PMC: 6914959. DOI: 10.1155/2019/8586167.


Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents.

Higgins V, Omidi A, Tahmasebi H, Asgari S, Gordanifar K, Nieuwesteeg M J Clin Endocrinol Metab. 2019; 105(4).

PMID: 31845996 PMC: 7077953. DOI: 10.1210/clinem/dgz161.


Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Parrinello C, Rudolph B, Lazo M, Gallo L, Thyagarajan B, Cotler S J Clin Gastroenterol. 2017; 53(2):e46-e53.

PMID: 29099463 PMC: 5934331. DOI: 10.1097/MCG.0000000000000946.


References
1.
Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K . Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006; 189(1):198-205. DOI: 10.1016/j.atherosclerosis.2005.11.036. View

2.
Goran M, Gower B . Longitudinal study on pubertal insulin resistance. Diabetes. 2001; 50(11):2444-50. DOI: 10.2337/diabetes.50.11.2444. View

3.
Hanley A, Williams K, Festa A, Wagenknecht L, DAgostino Jr R, Kempf J . Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004; 53(10):2623-32. DOI: 10.2337/diabetes.53.10.2623. View

4.
Chang Y, Ryu S, Sung E, Jang Y . Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007; 53(4):686-92. DOI: 10.1373/clinchem.2006.081257. View

5.
Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner S . Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care. 2005; 28(7):1757-62. DOI: 10.2337/diacare.28.7.1757. View